LON:NIPT Premaitha Health (NIPT) Share Forecast, Price & News GBX 9.10 +0.20 (+2.25%) (As of 11/6/2018) Add Compare Share Share Today's Range 9.10▼ 9.1050-Day Range 9.10▼ 9.1052-Week Range 3.78▼ 14.80Volume1.57 million shsAverage Volume1.35 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesProfileChartCompetitorsInsider TradesHeadlines About Premaitha Health (LON:NIPT) StockPremaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.Read More Receive NIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter. Email Address NIPT Stock News HeadlinesMay 14, 2023 | americanbankingnews.comPremaitha Health (LON:NIPT) Shares Pass Below 200 Day Moving Average of $9.10May 10, 2023 | marketwatch.comEurope Non Invasive Prenatal Testing Market Scope, Trends, Growth Status, Share, Revenue and Forecast 2023 to 2031June 3, 2023 | Behind the Markets (Ad)How A.I. Could Make Most 21st Century Diseases EXTINCTOn December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...May 10, 2023 | marketwatch.comNon-Invasive Prenatal Testing Market Key Players, Revenue, Share, Future Trends, Growth and Forecast 2023 to 2031May 5, 2023 | marketwatch.comNon Invasive Prenatal Testing (NIPT) Market Size (2023 to 2030) New Study on Global Industry Trends and Forecast with Top Countries DataMarch 18, 2023 | finance.yahoo.comNon-Invasive Prenatal Testing (NIPT) Market Growth (2022-2030) | Industry Share, Size, Trends and Global Forecast ReportMarch 9, 2023 | fool.co.ukPremaitha HealthFebruary 23, 2023 | uk.finance.yahoo.comNon-invasive Prenatal Testing Global Market Report 2023June 3, 2023 | Behind the Markets (Ad)How A.I. Could Make Most 21st Century Diseases EXTINCTOn December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...February 19, 2023 | marketwatch.comNon-Invasive Prenatal Testing (NIPT) Market 2023: A Status of Top Regions and Companies with Growth ProspectsJuly 12, 2022 | marketwatch.comIndia Non-Invasive Prenatal Testing (NIPT) Market Size to reach 62 Million USD by 2022-2028March 6, 2022 | fool.co.ukPersimmon (LSE:PSN)November 10, 2021 | lse.co.ukPremaitha Health Share ChatJanuary 11, 2021 | fool.co.uk(LSE:NIPT)December 23, 2020 | lse.co.ukRecent Broker Ratings for Panmure GordonNovember 28, 2020 | marketwatch.comNon invasive prenatal testing nipt market : Industry Development Scenario and ForecastMay 2, 2020 | finance.yahoo.comHealthcare Industry Trends And Its Impact On Premaitha Health PLC (LON:NIPT)May 2, 2020 | finance.yahoo.comWhat Investors Should Know About Premaitha Health PLC’s (LON:NIPT) Financial StrengthMay 2, 2020 | finance.yahoo.comWas Premaitha Health PLC’s (LON:NIPT) Earnings Growth Better Than The Industry’s?May 2, 2020 | finance.yahoo.comWhy Premaitha Health PLC’s (LON:NIPT) Ownership Structure Is ImportantMay 2, 2020 | finance.yahoo.comIs There Now An Opportunity In Premaitha Health PLC (LON:NIPT)?May 2, 2020 | finance.yahoo.comPremaitha Health PLC’s (LON:NIPT) Shift From Loss To ProfitMay 2, 2020 | finance.yahoo.comWho Owns Premaitha Health PLC (LON:NIPT)?January 17, 2020 | www.benzinga.comNon Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research®January 17, 2020 | www.marketwatch.comNon Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research(R)January 16, 2020 | www.marketwatch.comNon-invasive Prenatal Testing (NIPT) Market Opportunities, Size, Share, Emerging Trends, Technological Innovation And Forecasts To 2025November 18, 2019 | www.marketwatch.comNon-invasive Prenatal Testing (NIPT) Market Precise Study on Factors, Market Drivers and Key Players Strategies Analyzed Till 2025See More Headlines NIPT Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NIPT Company Calendar Last Earnings12/29/2017Today6/03/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Medical Laboratories & Research Sub-IndustryN/A SectorMedical Current SymbolLON:NIPT Previous SymbolLON:VIY CUSIPN/A CIKN/A Webwww.premaitha.com Phone+44-161-6676865FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesDr. Stephen Little (Age 61)Exec. Vice Chairman Mr. Barry HextallCFO, Sec. & Exec. DirectorMr. Peter Collins (Age 59)Chief Bus. Officer & Exec. Director Mr. Lyn Fafydd Rees (Age 45)CEO & Director Dr. Chia-Han Chan (Age 42)Chief Scientific Officer & Director Key CompetitorsAbzenaLON:ABZAAPR EnergyLON:APRCambian GroupLON:CMBNSinclair PharmaLON:SPHSummit TherapeuticsLON:SUMMView All Competitors NIPT Stock - Frequently Asked Questions How have NIPT shares performed in 2023? Premaitha Health's stock was trading at GBX 9.10 at the beginning of 2023. Since then, NIPT shares have increased by 0.0% and is now trading at GBX 9.10. View the best growth stocks for 2023 here. How were Premaitha Health's earnings last quarter? Premaitha Health PLC (LON:NIPT) announced its quarterly earnings data on Friday, December, 29th. The company reported ($2.00) earnings per share (EPS) for the quarter. The firm had revenue of $2.71 million for the quarter. What other stocks do shareholders of Premaitha Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV). What is Premaitha Health's stock symbol? Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT." How do I buy shares of Premaitha Health? Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Premaitha Health's stock price today? One share of NIPT stock can currently be purchased for approximately GBX 9.10. How can I contact Premaitha Health? Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The official website for the company is www.premaitha.com. The company can be reached via phone at +44-161-6676865. This page (LON:NIPT) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Premaitha Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.